Research and Development

Research and development is one of the pillars of River Pharma's success and is based on the ability to understand and anticipate the evolution of lifestyles, pathologies and habits of patients. Scientists, biologists, chemists and researchers are constantly engaged in exploring new possibilities to expand the boundaries of bioavailability, creating models in which scientific innovation is combined with the most advanced technologies, the synthesis of new formulas with the ability to rethink protocols and functionality.

Caring for people inspires all our decisions by shaping our ethical policy. It is the reason for our existence and it is also the central pillar of our Research and Development activities.

For this reason, we were among the first to develop and market nutraceuticals, cosmetics and medical devices based on High Molecular Weight Hyaluronic Acid. These products are characterised by the high standards of therapeutic efficacy and the high concentration of active ingredient.

River Pharma is one of the European companies that carries out research on the formulation of integrated therapeutic solutions based on hyaluronic acid. Systematic and extensive collaboration between researchers is creating new momentum. With our innovative solutions, we are responding to global challenges in the healthcare sector and the need to safeguard people's quality of life. Our success is based on excellence in research and development (R&D). The know-how and skills of our scientists and researchers are our most valuable asset in this endeavor. We develop new molecules and technologies in the research-intensive sectors of medicine and continuously invest in research and development projects. Today, the convergence of science and technology, coupled with the potential to exploit data in new dimensions, is radically changing research and development. Bespoke programmes and systematic and broad collaboration in research and development are creating new value for River Pharma and our customers.